日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis

通过血清蛋白质组分析检测系统性硬化症相关肺动脉高压血流动力学严重程度的生物标志物

Sanges, Sébastien; Rice, Lisa; Tu, Ly; Valenzi, Eleanor; Cracowski, Jean-Luc; Montani, David; Mantero, Julio C; Ternynck, Camille; Marot, Guillemette; Bujor, Andreea M; Hachulla, Eric; Launay, David; Humbert, Marc; Guignabert, Christophe; Lafyatis, Robert

Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis

更正:用于系统性硬化症肺动脉高压诊断评估的血清生物标志物

Rice, Lisa M; Mantero, Julio C; Stratton, Eric A; Warburton, Rod; Roberts, Kari; Hill, Nicholas; Simms, Robert W; Domsic, Robyn; Farber, Harrison W; Lafyatis, Robert

Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis.

Crenolanib 对 PDGF 受体的阻断作用在患者成纤维细胞和系统性硬化症的临床前模型中具有治疗效果

Makino Katsunari, Makino Tomoko, Stawski Lukasz, Mantero Julio C, Lafyatis Robert, Simms Robert, Trojanowska Maria

The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from Limited Cutaneous Systemic Sclerosis patients

HLA-B*35等位基因调节局限性皮肤系统性硬化症患者外周血单核细胞中的内质网应激、炎症和增殖

Lenna, Stefania; Assassi, Shervin; Farina, G Alessandra; Mantero, Julio C; Scorza, Raffaella; Lafyatis, Robert; Farber, Harrison W; Trojanowska, Maria